30013-X/asset/693f9505-3d2f-442f-9dc0-476c8f5248f0/main.assets/gr2_lrg.jpg)
semaglutide type 1 diabetes trial Efficacy and safety of once-weekly monotherapy versus placebo in patients with 2 (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a Weekly semaglutide improves blood sugar
Description
Primary progressive MS: Steady decline from onset
Yes, Wegovy can be used in people with type 2 diabetes, and it is one of the qualifying weight-related comorbidities that may make you eligible for treatment with a BMI of 27 or above
Women | Resistance training | Strength and body composition support | Metabolic and gut health support
For some, diet and exercise alone may not be enough
Eat well, feel great, and reach your health goals while on GLP-1 medications with this practical, science-backed cookbook
Please confirm your status as a healthcare professional to access the content.
